Martin Heidecker
Martin has been working at Boehringer Ingelheim since 2007 in a Senior Business Analyst and later in a Director capacity within the Global Business Analysis department. His responsibility incorporated all global strategic Marketing support in the arena of CNS and women’s health. This remit was later extended to include responsibility for the global Oncology Business Analysis as well.
Prior to joining BI, Martin held several positions within the global Business Intelligence Department of Solvay Pharmaceuticals focussing primarily on compounds in early clinical stages.
From 2002 – 2005 Martin worked as an investment manager at Bayern Kapital. During this time he led co-investments in early stage drug development, medical devices, and bioinformatic companies.
Martin holds Master’s degrees in Biology and Economics. In his Ph.D thesis he was focusing on membrane transport proteins.
Contact Venture Fund
-
Boehringer Ingelheim Venture Fund
Backoffice
Binger Strasse 173
55216 Ingelheim am Rhein
GERMANY- Phone +49 6132 77 8740
- contact
- Phone +49 6132 77 8740
